These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 19714597)

  • 1. The impact of flare on disease costs of patients with systemic lupus erythematosus.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Rheumatology (Oxford); 2009 May; 48(5):564-8. PubMed ID: 19269959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between flare and health-related quality of life in patients with systemic lupus erythematosus.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    J Rheumatol; 2010 Mar; 37(3):568-73. PubMed ID: 20110519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs associated with severe and nonsevere systemic lupus erythematosus in Canada.
    Clarke AE; Urowitz MB; Monga N; Hanly JG
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):431-6. PubMed ID: 25185936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Socioeconomic burden of psoriatic arthritis in Hong Kong: direct and indirect costs and the influence of disease pattern.
    Zhu TY; Tam LS; Leung YY; Kwok LW; Wong KC; Yu T; Kun EW; Li EK
    J Rheumatol; 2010 Jun; 37(6):1214-20. PubMed ID: 20360186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of disease activity, treatment and disease severity on short-term costs of systemic lupus erythematosus.
    Lacaille D; Clarke AE; Bloch DA; Danoff D; Esdaile JM
    J Rheumatol; 1994 Mar; 21(3):448-53. PubMed ID: 8006887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian failure and flares of systemic lupus erythematosus.
    Mok CC; Wong RW; Lau CS
    Arthritis Rheum; 1999 Jun; 42(6):1274-80. PubMed ID: 10366122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population.
    Li T; Carls GS; Panopalis P; Wang S; Gibson TB; Goetzel RZ
    Arthritis Rheum; 2009 Jun; 61(6):755-63. PubMed ID: 19479688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB; Ibañez D; Jerome D; Gladman DD
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flares in pediatric systemic lupus erythematosus.
    Weiss JE; Sison CP; Ilowite NT; Gottlieb BS; Eberhard BA
    J Rheumatol; 2007 Jun; 34(6):1341-4. PubMed ID: 17477466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreasing costs and improving outcomes in systemic lupus erythematosus: using regression trees to develop health policy.
    Clarke AE; Bloch DA; Danoff DS; Esdaile JM
    J Rheumatol; 1994 Dec; 21(12):2246-53. PubMed ID: 7699625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and quality of life of patients with ankylosing spondylitis in Canada.
    Kobelt G; Andlin-Sobocki P; Maksymowych WP
    J Rheumatol; 2006 Feb; 33(2):289-95. PubMed ID: 16465660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with active systemic lupus erythematosus after endstage renal disease.
    Szeto CC; Li PK; Wong TY; Leung CB; Lui SF
    J Rheumatol; 1998 Aug; 25(8):1520-5. PubMed ID: 9712094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.
    Zhu TY; Tam LS; Li EK
    Rheumatology (Oxford); 2011 Jul; 50(7):1293-301. PubMed ID: 21330341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports.
    Bexelius C; Wachtmeister K; Skare P; Jönsson L; Vollenhoven Rv
    Lupus; 2013 Jul; 22(8):793-801. PubMed ID: 23761101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE Study.
    Cervera R; Rúa-Figueroa I; Gil-Aguado A; Sabio JM; Pallarés L; Hernández-Pastor LJ; Iglesias M
    Rev Clin Esp (Barc); 2013 Apr; 213(3):127-37. PubMed ID: 23398815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients.
    Michaud K; Messer J; Choi HK; Wolfe F
    Arthritis Rheum; 2003 Oct; 48(10):2750-62. PubMed ID: 14558079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs and quality of life of patients with ankylosing spondylitis in Hong Kong.
    Zhu TY; Tam LS; Lee VW; Hwang WW; Li TK; Lee KK; Li EK
    Rheumatology (Oxford); 2008 Sep; 47(9):1422-5. PubMed ID: 18635597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Climatic influence on the prevalence of noncutaneous disease flare in systemic lupus erythematosus in Hong Kong.
    Szeto CC; Mok HY; Chow KM; Lee TC; Leung JY; Li EK; Tsui TK; Yu S; Tam LS
    J Rheumatol; 2008 Jun; 35(6):1031-7. PubMed ID: 18398942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.
    Khamashta MA; Bruce IN; Gordon C; Isenberg DA; Ateka-Barrutia O; Gayed M; Donatti C; Guillermin AL; Foo J; Perna A
    Lupus; 2014 Mar; 23(3):273-83. PubMed ID: 24356612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.